HÄMOGLOBINMODULATOREN
European patent · EP4126832 · Deleted
Register entry
- Publication number
- EP4126832
- Application number
- EP21719796
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Mar 26, 2021
- Published
- Feb 8, 2023
- Granted
- Jan 7, 2026
- Deleted
- Oct 23, 2026
- Reason
- Annual fee unpaid
- IPC classes
- C07D 295/192 (2006.01)C07D 401/06 (2006.01)A61P 7/06 (2006.01)A61K 31/445 (2006.01)A61K 31/5375 (2006.01)A61K 31/54 (2006.01)
- Priority
- US 202063003104 P 31.03.2020US 202063003106 P 31.03.2020
- PCT application
- PCT/US2021/024384 26.03.2021
- PCT publication
- WO2021/202284 07.10.2021
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 23, 2026
Deleted, fee unpaid
- Status of protective title
- Active → Cancelled
- Cancellation date
- 23.10.2026
- Cause for cancellation
- Non-payment of renewal fee
Published in Swissreg on 23.10.2026
- Jan 7, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 07.01.2026
Parties
Holder
Global Blood Therapeutics, Inc.
South San Francisco, CA 94080, US
Inventor
LI, Zhe
South San Francisco, CA 94080, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.